543828-BOM

Sudarshan Pharma Industries Ltd.

BSE: 543828

SME

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Specialty Chemicals

40.00-0.3 (-0.77%)

17 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

34.6 / 100

Value Score

43.8 / 100

Price Momentum Score

96.0 / 100

QVM Score

64.1 / 100

Key Metrics

Market Cap

998.64

P/E (TTM)

42.85

P/B

6.44

P/S (TTM)

1.42

EV/EBITDA

24.80

CAPE (5Y)

62.57

ROE (TTM)

16.26

ROCE (TTM)

12.78

ROA (TTM)

4.46

Avg 3Y ROE

13.39

Earnings 3Y CAGR

21.00

Sales 3Y CAGR

15.08

Sales 5Y CAGR

29.46

Debt/Equity

1.84

Consensus TP

Strong Buy %

Promoter Holding

57.39

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Sudarshan Pharma Industries Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 96.0 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

96.0 / 100

High and improving ROE

The company reported strong ROE of 16.26% for 12-month ended 31 Mar 2026 and ROE improved by 314 bps from 1 year ago

What is ROE (FY)?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 39.21% for 12-month ended 31 Mar 2026 and the growth was 28.17 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.04

Value 39.21

-46.16485295

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 47.22% for 12-month ended 31 Mar 2026 and the growth was 44.27 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 42.85 indicates that the stock is expensive on a standalone basis and is at a 59.77% premium to industry median P/E

What is P/E Ratio?

Median: 26.82

Value 42.85

1.94811.51

Low but stable operating margin

The company reported low operating margin of 6.76% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -69 bps from 1 year ago

What is Operating profit margin?

Reasonable Debt to Equity, but increasing

The company has reasonable Debt to Equity of 1.84 as on 31 Mar 2026 but Debt to Equity increased by 0.54 in the last 1 year

What is Debt to Equity?

Company's earnings are of low quality

Earnings quality score of 21.4 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

21.4 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Sudarshan Pharma Industries Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Sudarshan Pharma Industries Ltd. Shareholding Pattern

Quarterly breakdown of Sudarshan Pharma Industries Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Aug 2018	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	89.28	57.39	57.39	57.39	57.39	57.39	57.39	57.39	57.39	57.39
Indian Promoter	89.28	57.39	57.39	57.39	57.39	57.39	57.39	57.39	57.39	57.39
Foreign Promoter	0.00	-	-	-	-	-	-	-	-	-
Institutions	0.00	3.58	1.40	1.40	13.07	18.45	19.53	20.84	19.83	20.00
Mutual Funds / UTI	0.00	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	-	-	-	-	-	0.05	0.05	0.05	0.05
FII	0.00	3.58	1.40	1.40	13.07	18.45	19.49	20.79	19.78	19.95
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	10.72	39.03	41.21	41.21	29.54	24.16	23.07	21.77	22.78	22.61
Bodies Corporate	0.00	14.49	9.62	13.08	4.28	3.99	4.48	3.84	4.29	4.55
Others (incl. Retail) No. of shareholders	10.72 0	24.54 1,221	31.59 949	28.13 873	25.26 724	20.17 1,144	18.59 1,260	17.93 1,318	18.49 1,343	18.06 1,284

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sudarshan Pharma Industries Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Sudarshan Pharma Industries Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Stock Split1 : 10
Ex-date: 22nd Nov 2024Announced on: 30th Sep 2024
Nominal Value change from INR 10 to INR 01.
Dividend₹ 0.30/share
Record date: 26th Aug 2023Ex-date: 25th Aug 2023
Announced on: 21st Jul 2023

Company Profile

Overview of Sudarshan Pharma Industries Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma...

Key personnel

Mr. Sharad Govindrao Kathawate

Chief Financial Officer

Mr. Nirav Shah

Compliance Officer, Company Secretary

Mr. Indraraj Neogi

Head of Sales and Marketing of Pharma Division

Mr. Shrinivas Patil

Exports

Mr. Santosh Thakur

Import Sourcing and Indenting

Mr. Hemal Vasantrai MehtaD

Managing Director, Executive Chairman of the Borad

Mr. Anil Balkrishna GhogareD

Additional Non-Executive Director

Dr. Vinay Kumar PandeyD

Additional Non-Executive Director

View all

Incorporated on

17 Dec 2016

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

22 Mar 2023

Free Float

6,25,93,290

Website

https://www.sudarshanpharma.com

Phone no.

+912242221100

Address

301, 3rd Floor, Aura Biplex Landmark, Kalyan Jewellers, S V Road, Borivali (W), MUMBAI, 400092, India

Frequently Asked Questions

What is the current share price of Sudarshan Pharma Industries Ltd.?

The current share price of Sudarshan Pharma Industries Ltd. is ₹ 40.00 as of 17 Jul 2026.

What is the market capitalisation of Sudarshan Pharma Industries Ltd.?

The market capitalisation of Sudarshan Pharma Industries Ltd. stands at ₹ 998.64 Cr.

What is the PE ratio of Sudarshan Pharma Industries Ltd.?

The Price-to-Earnings (PE) ratio of Sudarshan Pharma Industries Ltd. is 42.85 as of the latest trailing twelve months data.

What is the ROE and ROCE of Sudarshan Pharma Industries Ltd.?

Sudarshan Pharma Industries Ltd. has a Return on Equity (ROE) of 16.26% and a Return on Capital Employed (ROCE) of 12.78% as per the latest financial reports.

What is the 52-week high and low of Sudarshan Pharma Industries Ltd.?

The 52-week high of Sudarshan Pharma Industries Ltd. is - and the 52-week low is -.

What is the dividend yield of Sudarshan Pharma Industries Ltd.?

The dividend yield of Sudarshan Pharma Industries Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Sudarshan Pharma Industries Ltd.?

Foreign Institutional Investors (FII) hold 19.95%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 18.06% of Sudarshan Pharma Industries Ltd. shares.

What sector does Sudarshan Pharma Industries Ltd. belong to?

Sudarshan Pharma Industries Ltd. operates in the Chemicals sector.

What is the beta of Sudarshan Pharma Industries Ltd.?

The beta of Sudarshan Pharma Industries Ltd. is 0.70, indicating its price volatility relative to the broader market. Over the past 1 year, Sudarshan Pharma Industries Ltd. has delivered an absolute return of 37.93%.

What is the RSI of Sudarshan Pharma Industries Ltd.?

The 14-day Relative Strength Index (RSI) of Sudarshan Pharma Industries Ltd. is 55.88, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Sudarshan Pharma Industries Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Sudarshan Pharma Industries Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Corporate Actions

Stock Analysis

Company Profile